Informations générales
  • Catégorie de maladie Maladies de la peau et du tissu conjonctif (hors cancer) (BASEC)
  • État du recrutement recrutement pas encore commencé (BASEC/ICTRP)
  • Lieu de l’étude
    Zurich
    (BASEC)
  • Responsable de l'étude Galya Dragieva info@drdragieva.ch (BASEC)
  • Source(s) de données BASEC: Importé de 04.08.2026 ICTRP: N/A
  • Date de mise à jour 04.08.2026 15:50
HumRes68321 | SNCTP000006945 | BASEC2025-02042

Investigation of a New Autologous Fat Method for Natural Facial Rejuvenation

  • Catégorie de maladie Maladies de la peau et du tissu conjonctif (hors cancer) (BASEC)
  • État du recrutement recrutement pas encore commencé (BASEC/ICTRP)
  • Lieu de l’étude
    Zurich
    (BASEC)
  • Responsable de l'étude Galya Dragieva info@drdragieva.ch (BASEC)
  • Source(s) de données BASEC: Importé de 04.08.2026 ICTRP: N/A
  • Date de mise à jour 04.08.2026 15:50

Résumé de l'étude

This clinical study tests a new method for natural facial rejuvenation using the patient's own fat. A particularly fine, cell-rich portion is obtained from a small fat sample of the patient ('nanofat') and mixed with autologous blood plasma (PRP). This regenerative mixture is applied to different skin layers of the face – under the skin, with a microneedling device, and partially also superficially after laser treatment.

The aim of the study is to examine how well the skin and tissue regenerate after treatment, how quickly healing occurs, and how appearance improves – for example, in terms of freshness, firmness, skin texture, and facial contours. Part of the participants will be treated slightly differently on each side of the face to directly compare which application yields the best results.

The treatment lasts about one hour and is performed on an outpatient basis. The procedure uses only the body's own substances and is therefore very well tolerated. After treatment, temporary redness or swelling may occur, which usually subsides within one to two days.

Participants will be followed up for twelve months. During this time, photos will be taken, satisfaction questionnaires will be filled out, and the healing process will be documented. The goal is to develop a safe, sustainable, and natural method for improving skin quality and facial freshness.

(BASEC)

Intervention étudiée

Autologous nanofat treatment, enriched with platelet-rich plasma (PRP).
The autologous fat is obtained through micro-liposuction, mechanically processed (Lipocube™ Nano), enriched with 20% PRP, and applied in several skin layers: subcutaneously, intradermally via an oscillating microneedling device (> 50,000 microchannels/min), as well as partially topically after fractional CO₂ laser treatment.
Various application combinations (nanofat + microneedling ± laser) are being investigated regarding regeneration, healing process, and aesthetic outcome.

(BASEC)

Maladie en cours d'investigation

Facial aging (age-related changes in skin structure, elasticity, and contours).
Regenerative procedures for improving skin quality, elasticity, and tissue structure in the context of aesthetic-dermatological facial rejuvenation are being investigated.

(BASEC)

Critères de participation

Adult women and men aged ≥ 30 and ≤ 70 years with visible age-related changes in facial skin (e.g., loss of elasticity, wrinkles, dull complexion).
Generally good health and suitability for outpatient aesthetic procedures.
Written informed consent after comprehensive information.

(BASEC)


Critères d'exclusion

Pregnancy or breastfeeding.

Acute or chronic skin diseases, infections, or scars in the treatment area.
Coagulation disorders, severe systemic diseases, or known intolerance to local anesthetics.

(BASEC)

Lieu de l’étude

Zurich

(BASEC)

non disponible

Sponsor

No sponsor.

(BASEC)

Contact pour plus d'informations sur l'étude

Personne de contact en Suisse

Galya Dragieva

+41 44 383 33 00

info@drdragieva.ch

Dr. Dragieva Aesthetics

(BASEC)

Informations scientifiques

non disponible

Nom du comité d'éthique approbateur (pour les études multicentriques, uniquement le comité principal)

Commission cantonale de Zurich

(BASEC)

Date d'approbation du comité d'éthique

09.06.2026

(BASEC)


Identifiant de l'essai ICTRP
non disponible

Titre officiel (approuvé par le comité d'éthique)
PROSPECTIVE, SPLIT-FACE RANDOMIZED EVALUATION OF A NOVEL, SYNERGISTIC MULTILAYER NANOFAT TECHNIQUE FOR FACIAL REJUVENATION (BASEC)

Titre académique
non disponible

Titre public
non disponible

Maladie en cours d'investigation
non disponible

Intervention étudiée
non disponible

Type d'essai
non disponible

Plan de l'étude
non disponible

Critères d'inclusion/exclusion
non disponible

non disponible

Critères d'évaluation principaux et secondaires
non disponible

non disponible

Date d'enregistrement
non disponible

Inclusion du premier participant
non disponible

Sponsors secondaires
non disponible

Contacts supplémentaires
non disponible

ID secondaires
non disponible

Résultats-Données individuelles des participants
non disponible

Informations complémentaires sur l'essai
non disponible

Résultats de l'essai

Résumé des résultats

non disponible

Lien vers les résultats dans le registre primaire

non disponible